English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Ruth de Jauregui | Jun 7, 2017

Study indicates positive results using smaller, combination doses of blood pressure medication

Ruth de Jauregui | Jun 7, 2017

Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer

Ruth de Jauregui | Jun 7, 2017

AstraZeneca sees positive results in treating BRCA-mutated breast cancer patients with Lynparza

Erianne Leatherman | Jun 6, 2017

Novartis highlighting cancer care data at national, international forums

Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer

Ruth de Jauregui | Jun 4, 2017

Advaxis, Bristol-Myers Squibb to collaborate in metastatic cervical cancer study

Erianne Leatherman | Jun 4, 2017

Revision to heart failure guideline released

Ruth de Jauregui | Jun 4, 2017

National Institute of Health announces promising influenza study tool

Trending

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’

+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’

  • « First
  • «
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily